858 Therapeutics

San Diego, United States

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

$50.0M raised

Sep 2024

Series B

Biotechnology Health Care Pharmaceutical

Top Investors

Insight PartnersNew Enterprise AssociatesCormorant Asset ManagementVersant VenturesAvidity Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about 858 Therapeutics

How much funding has 858 Therapeutics raised?

858 Therapeutics has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in September 2024.

Who are 858 Therapeutics's investors?

858 Therapeutics's investors include Insight Partners, New Enterprise Associates, Cormorant Asset Management, Versant Ventures, Avidity Partners.

Where is 858 Therapeutics headquartered?

858 Therapeutics is headquartered in San Diego, United States.

What does 858 Therapeutics do?

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

What stage is 858 Therapeutics at?

858 Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 26, 2024.

MLA

"858 Therapeutics — Funding & Investors." VCBacked, September 26, 2024, https://www.vcbacked.co/company/858-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2024). 858 Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/858-therapeutics

Wikipedia (cite web)

{{cite web |title=858 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/858-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 26, 2024.

Similar Companies in Biotechnology